Mutation Analysis (MutSigCV v0.9)
Lung Squamous Cell Carcinoma (Primary solid tumor)
23 May 2013  |  analyses__2013_05_23
Maintainer Information
Citation Information
doi:10.7908/C1PK0D6S
Maintained by Dan DiCara (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Mutation Analysis (MutSigCV v0.9). Broad Institute of MIT and Harvard. doi:10.7908/C1PK0D6S
Overview
Introduction

This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSigCV v0.9 was used to generate the results found in this report.

  • Working with individual set: LUSC-TP

  • Number of patients in set: 178

Input

The input for this pipeline is a set of individuals with the following files associated for each:

  1. An annotated .maf file describing the mutations called for the respective individual, and their properties.

  2. A .wig file that contains information about the coverage of the sample.

Summary
Results
Target Coverage for Each Individual

The x axis represents the samples. The y axis represents the exons, one row per exon, and they are sorted by average coverage across samples. For exons with exactly the same average coverage, they are sorted next by the %GC of the exon. (The secondary sort is especially useful for the zero-coverage exons at the bottom).

Figure 1. 

Distribution of Mutation Counts, Coverage, and Mutation Rates Across Samples

Figure 2.  Patients counts and rates file used to generate this plot: LUSC-TP.patients.counts_and_rates.txt

Needs description.

Figure 3.  Needs description.

Figure 4.  Needs description.

CoMut Plot

Figure 5.  Get High-res Image The matrix in the center of the figure represents individual mutations in patient samples, color-coded by type of mutation, for the significantly mutated genes. The rate of synonymous and non-synonymous mutations is displayed at the top of the matrix. The barplot on the left of the matrix shows the number of mutations in each gene. The percentages represent the fraction of tumors with at least one mutation in the specified gene. The barplot to the right of the matrix displays the q-values for the most significantly mutated genes. The purple boxplots below the matrix (only displayed if required columns are present in the provided MAF) represent the distributions of allelic fractions observed in each sample. The plot at the bottom represents the base substitution distribution of individual samples, using the same categories that were used to calculate significance.

Significantly Mutated Genes

Column Descriptions:

  • nnon = number of (nonsilent) mutations in this gene across the individual set

  • npat = number of patients (individuals) with at least one nonsilent mutation

  • nsite = number of unique sites having a non-silent mutation

  • nflank = number of noncoding mutations from this gene's flanking region, across the individual set

  • nsil = number of silent mutations in this gene across the individual set

  • p = p-value (overall)

  • q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

Table 1.  Get Full Table A Ranked List of Significantly Mutated Genes. Number of significant genes found: 12. Number of genes displayed: 35. Click on a gene name to display its stick figure depicting the distribution of mutations and mutation types across the chosen gene (this feature may not be available for all significant genes).

gene Nnon Nsil Nflank nnon npat nsite nsil nflank nnei fMLE p score time q
TP53 168210 49128 206 147 141 98 7 0 4 3 3.7e-15 430 0.13 6.7e-11
CDKN2A 107156 30438 62 26 26 23 1 0 6 2 1.1e-14 97 0.13 1e-10
PTEN 173372 41652 174 16 14 15 0 0 20 0.93 6.4e-11 62 0.13 3.9e-07
NFE2L2 250802 66394 81 28 27 15 0 0 20 1.3 4.7e-10 68 0.13 2.1e-06
KEAP1 231400 67640 87 24 22 21 0 0 20 0.55 7.2e-10 60 0.13 2.6e-06
CSMD3 1583488 442508 1422 124 81 122 21 0 5 2.8 3.2e-08 160 0.13 0.000097
MLL2 1885198 623178 771 41 35 41 6 0 20 0.73 5.2e-08 110 0.13 0.00014
PIK3CA 462622 118370 396 29 27 16 1 0 20 0.86 6.2e-07 60 0.13 0.0014
RB1 506944 133678 486 12 12 12 0 0 20 0.61 1.5e-06 54 0.12 0.003
ELTD1 288894 77252 288 18 18 18 2 0 15 1.6 5.4e-06 55 0.12 0.0098
ASCL4 31328 11392 10 6 6 6 0 0 20 1 0.000015 25 0.12 0.026
FBXW7 345676 94874 239 11 11 9 3 0 20 0.54 0.000028 41 0.12 0.043
OR2G6 128694 40228 24 17 16 17 4 0 20 2 0.000088 37 0.14 0.12
COL11A1 762018 239232 1271 46 35 46 8 0 18 2.1 0.00031 81 0.13 0.4
LRRC4C 262728 78676 24 19 17 19 1 0 13 1 0.00038 41 0.13 0.47
HLA-A 145960 44144 154 7 6 7 0 0 20 0.88 0.00053 31 0.12 0.61
LEPROT 53400 16198 64 4 4 4 0 0 15 0.93 0.00094 19 0.12 0.83
APOBEC1 102350 26522 103 7 7 7 1 0 20 0.74 0.00097 22 0.12 0.83
APLNR 152368 46102 24 7 7 7 0 0 20 0.73 0.00097 27 0.12 0.83
FAM58B 99146 30082 12 5 5 5 1 0 20 0.86 0.00097 23 0.12 0.83
OR6F1 124600 40050 24 13 13 13 2 0 20 2 0.001 30 0.13 0.83
PACRGL 94162 28124 143 5 5 5 0 0 20 1.2 0.0011 23 0.12 0.83
SPANXN1 32396 7120 44 5 5 5 0 0 20 3 0.0011 20 0.11 0.83
TGIF2LX 99324 28658 24 12 9 12 1 0 20 2 0.0011 29 0.12 0.83
CERK 193308 53400 208 6 6 6 1 0 20 0.66 0.0013 25 0.12 0.95
ALPK2 908512 255252 243 18 18 17 2 0 15 0.6 0.0014 51 0.13 0.95
GPR174 135458 38270 24 6 5 6 1 0 19 0.69 0.0014 23 0.13 0.95
ZFP42 129584 35956 23 8 8 8 0 0 20 1.3 0.0015 27 0.12 0.95
ZNF80 116234 29548 24 7 7 7 1 0 20 1.3 0.0016 25 0.12 1
CLSTN2 389820 104842 310 18 17 18 2 0 20 1.8 0.0017 49 0.13 1
FAM5C 323248 88288 141 28 27 28 3 0 20 2.5 0.0017 52 0.13 1
FAM159A 72802 21004 52 5 5 5 1 0 20 0.55 0.0019 18 0.11 1
ZBBX 349414 85974 356 17 17 17 1 0 20 1.8 0.0019 44 0.12 1
HS6ST1 106622 31506 16 5 5 5 0 0 20 0.45 0.0019 20 0.12 1
NOTCH1 710754 205412 380 18 14 18 3 0 20 0.77 0.0021 51 0.13 1
TP53

Figure S1.  This figure depicts the distribution of mutations and mutation types across the TP53 significant gene.

CDKN2A

Figure S2.  This figure depicts the distribution of mutations and mutation types across the CDKN2A significant gene.

PTEN

Figure S3.  This figure depicts the distribution of mutations and mutation types across the PTEN significant gene.

NFE2L2

Figure S4.  This figure depicts the distribution of mutations and mutation types across the NFE2L2 significant gene.

KEAP1

Figure S5.  This figure depicts the distribution of mutations and mutation types across the KEAP1 significant gene.

CSMD3

Figure S6.  This figure depicts the distribution of mutations and mutation types across the CSMD3 significant gene.

MLL2

Figure S7.  This figure depicts the distribution of mutations and mutation types across the MLL2 significant gene.

PIK3CA

Figure S8.  This figure depicts the distribution of mutations and mutation types across the PIK3CA significant gene.

RB1

Figure S9.  This figure depicts the distribution of mutations and mutation types across the RB1 significant gene.

ELTD1

Figure S10.  This figure depicts the distribution of mutations and mutation types across the ELTD1 significant gene.

ASCL4

Figure S11.  This figure depicts the distribution of mutations and mutation types across the ASCL4 significant gene.

FBXW7

Figure S12.  This figure depicts the distribution of mutations and mutation types across the FBXW7 significant gene.

Methods & Data
Methods

In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] TCGA, Integrated genomic analyses of ovarian carcinoma, Nature 474:609 - 615 (2011)
Copyright © 2013 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle